Patents by Inventor Marina STASENKO

Marina STASENKO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODIES TO GALECTIN-3 AND METHODS OF USE THEREOF
    Publication number: 20250353915
    Abstract: Provided herein are compositions, methods, and uses involving antibodies that immunospecifically bind the Galactin-3 (LGALS3) carbohydrate binding domain (CBD). Also provided herein are uses and methods for managing, treating, or preventing disorders, such as cancer.
    Type: Application
    Filed: December 12, 2024
    Publication date: November 20, 2025
    Inventors: David SPRIGGS, Dharmarao THAPI, Marina STASENKO
  • Antibodies to galectin-3 and methods of use thereof
    Patent number: 12180285
    Abstract: Provided herein are compositions, methods, and uses involving antibodies that immunospecifically bind the Galactin-3 (LGALS3) carbohydrate binding domain (CBD). Also provided herein are uses and methods for managing, treating, or preventing disorders, such as cancer.
    Type: Grant
    Filed: February 1, 2019
    Date of Patent: December 31, 2024
    Assignee: Memorial Sloan Kettering Cancer Center
    Inventors: David Spriggs, Dharmarao Thapi, Marina Stasenko
  • ANTIBODIES TO GALECTIN-3 AND METHODS OF USE THEREOF
    Publication number: 20210032350
    Abstract: Provided herein are compositions, methods, and uses involving antibodies that immunospecifically bind the Galactin-3 (LGALS3) carbohydrate binding domain (CBD). Also provided herein are uses and methods for managing, treating, or preventing disorders, such as cancer.
    Type: Application
    Filed: February 1, 2019
    Publication date: February 4, 2021
    Applicant: MEMORIAL SLOAN KETTERING CANCER CENTER
    Inventors: David SPRIGGS, Dharmarao THAPI, Marina STASENKO